Apogee Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Apogee Therapeutics, Inc. (APGE) had Deferred Tax Assets, Operating Loss Carryforwards of $58.58 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-02
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $58.58M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.09M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.37M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $620.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $58.58M 10-K · filed 2026-03-02 |
| 2024-12-31 | $16.09M 10-K · filed 2026-03-02 |
| 2023-12-31 | $5.37M 10-K · filed 2026-03-02 |
| 2022-12-31 | $620.00K 10-K · filed 2024-03-05 |